| Dr Madhusudanan Srambickal Ramaswamy, MD, MS | |
|
4320 Seminary Rd, Alexandria, VA 22304-1535 | |
| (703) 504-3000 | |
| (571) 285-0027 |
| Full Name | Dr Madhusudanan Srambickal Ramaswamy |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 4320 Seminary Rd, Alexandria, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013165455 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | P61007 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Northern Virginia Medical Center | Woodbridge, VA | Hospital |
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20110104000695 |
News Archive
A new study published in the journal PLOS Medicine shows that the number of prostate cancer deaths could be reduced by a sixth by simply introducing targeted screening, which is directed at detecting cases among men whose genes put them at higher risk of the disease.
Camelot Healthcare Training Institute, a post-secondary nursing and allied health care education provider in Central Florida, has been acquired by Medtech College. Camelot now joins the Medtech family of schools and will become Medtech College once appropriate state approvals have been obtained.
Researchers at ETH Zurich and ETH spin-off Inositec have developed a new substance to prevent vascular calcification, which affects many patients suffering from chronic kidney disease.
BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical testing of ProtoCure emulsion cream, the company's novel topical drug for dermatology.
› Verified 8 days ago
| Entity Name | Capital Critical Care & Informatics Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104319698 PECOS PAC ID: 6800144130 Enrollment ID: O20180802003253 |
News Archive
A new study published in the journal PLOS Medicine shows that the number of prostate cancer deaths could be reduced by a sixth by simply introducing targeted screening, which is directed at detecting cases among men whose genes put them at higher risk of the disease.
Camelot Healthcare Training Institute, a post-secondary nursing and allied health care education provider in Central Florida, has been acquired by Medtech College. Camelot now joins the Medtech family of schools and will become Medtech College once appropriate state approvals have been obtained.
Researchers at ETH Zurich and ETH spin-off Inositec have developed a new substance to prevent vascular calcification, which affects many patients suffering from chronic kidney disease.
BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical testing of ProtoCure emulsion cream, the company's novel topical drug for dermatology.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Madhusudanan Srambickal Ramaswamy, MD, MS 2776 S Arlington Mill Dr # 103, Arlington, VA 22206-3402 Ph: (571) 308-6768 | Dr Madhusudanan Srambickal Ramaswamy, MD, MS 4320 Seminary Rd, Alexandria, VA 22304-1535 Ph: (703) 504-3000 |
News Archive
A new study published in the journal PLOS Medicine shows that the number of prostate cancer deaths could be reduced by a sixth by simply introducing targeted screening, which is directed at detecting cases among men whose genes put them at higher risk of the disease.
Camelot Healthcare Training Institute, a post-secondary nursing and allied health care education provider in Central Florida, has been acquired by Medtech College. Camelot now joins the Medtech family of schools and will become Medtech College once appropriate state approvals have been obtained.
Researchers at ETH Zurich and ETH spin-off Inositec have developed a new substance to prevent vascular calcification, which affects many patients suffering from chronic kidney disease.
BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical testing of ProtoCure emulsion cream, the company's novel topical drug for dermatology.
› Verified 8 days ago
George Peter Silis, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5115 Franconia Road, Sutie G, Alexandria, VA 22310 Phone: 703-922-4222 Fax: 703-922-4253 | |
Nabeela Tabassum, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 4810 Beauregard St, Ste 303, Alexandria, VA 22312 Phone: 703-750-0108 Fax: 703-750-0230 | |
Dr. Chinedu Madu, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4825 Mark Center Dr Ste 150, Alexandria, VA 22311 Phone: 703-751-8111 Fax: 703-751-1105 | |
Kim-dung T Nguyen, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5130 Duke St, 8, Alexandria, VA 22304 Phone: 703-823-2849 Fax: 703-823-2847 | |
Dr. Muhammed F. Khokhar, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave Ste 810, Alexandria, VA 22304 Phone: 703-823-0333 Fax: 703-823-8611 | |
Tariq Rehman, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4141a Duke St, Alexandria, VA 22304 Phone: 703-461-3556 Fax: 703-461-8075 |